Hospital Universitario Principe De Asturias — Clinical Trial Site

16 Registered trials

10 Currently recruiting

Organisation

Hospital Universitario Principe De Asturias

Location

Alcala De Henares, Spain

Identifier

ORG-100028565

Address

Carretera Meco S/n, 28805, Spain

Departments

Cirugía
DIGESTIVE DISEASE
Endocrinology
Haematology
Hematología
Hematology
Medicina Interna
Nephrology
Ophtalmology
Orthopedic Surgery and Traumatology Service (Knee Unit)
Servicio de Medicina Interna

Clinical trials at this site (16)

Search interface

OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending

2025-520554-11-00 Cardiovascular Disease 5
Clinical trial on the assessment of mucosal visualization quality and diagnostic performance in small bowel capsule endoscopy using differen… Pending

2025-520671-38-00 Comparison of diagnostic tools 11
A trial to learn if odronextamab is safe and well-tolerated and how well it works compared to rituximab combined with different types of che… Recruiting

2022-502660-20-00 Follicular lymphoma 5 2024-01-23
Combined Dose-Finding and CV Outcomes Study with CSL300 (Clazakizumab) in Adult Subjects with ESKD Undergoing Dialysis (POSIBIL6ESKD). Recruiting

2022-500273-14-00 Atherosclerotic cardiovascular disease in patients with 10 2023-07-17
A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s … Recruiting

2025-522979-29-00 Acute myeloid leukemia 5 2026-04-30
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
A study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diab… Recruiting

2024-519494-19-00 Nutritional and metabolic diseases 5 2025-12-22
Prospective Randomized Evaluation of Emerging Novel Treatments for Infection prophylaxis in Total Joint Replacement (PREVENT-iT) Recruiting

2024-515055-38-00 Adult patients undergoing TJR surgery. 5 2025-02-13
Double-blind, randomized, placebo-controlled, pilot clinical trial to evaluate the safety, tolerability and efficacy of two doses of a condi… Recruiting

2023-507700-32-00 Acute respiratory distress syndrome (ARDS) caused by SA 1 2024-10-02
A multicentric, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of COLIRIOBCN070660 administered topically in pa… Recruiting

2023-505791-30-01 Diabetic Retinopathy 10 2024-04-17
Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting

2023-508442-18-00 Patients with an infection of the osteosynthesis materi 5 2024-04-14
Multicentre Phase IV clinical trial to evaluate the efficacy of hyperthermic intraoperative chemotherapy (HIPEC) with Mitomycin-C after comp… Recruiting

2024-512726-28-00 peritoneal metastases of colorectal cancer 6 2022-02-14
A study to determine if ravulizumab can help preserve kidney function in adults with immunoglobulin A nephropathy (IgAN) Ended

2023-507851-31-00 Immunoglobulin A Nephropathy (IgAN) 5 2024-09-23
A Combination of Acalabrutinib with R-CHOP in Subjects with previously untreated non-GCB DLBCL Ended

2023-509358-72-00 Diffuse large B-cell lymphoma 5 2020-11-23
A study to learn how well the treatment combination of finerenone and empagliflozin works and how safe it is compared to each treatment alon… Ended

2023-506981-30-00 Chronic kidney disease in type 2 diabetes mellitus 4 2022-05-25
A trial to learn how well finerenone works and how safe it is in adult participants with non-diabetic chronic kidney disease Ended

2023-506897-11-00 Non-diabetic chronic kidney disease 5 2021-10-18